Low mortality rates related to respiratory virus infections after bone marrow transplantation

Clarisse Martins Machado, Cláudio Mendes Pannuti, Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), I F da Rocha(Universidade de São Paulo), F L Dulley(Universidade de São Paulo), Maria Alany Ferreira Dos Santos(Universidade de São Paulo), Lucy Santos Vilas Boas(Universidade de São Paulo), Daniel Sturaro(Universidade de São Paulo)
Bone Marrow Transplantation
April 1, 2003
10.1038/sj.bmt.1703900
Cited by 104

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
|Emerging infectious diseases|2021|215
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
|Biomedicine & Pharmacotherapy|2021|121